Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 61,580 | 226,443 | 252,004 | 142,117 | 9,238 |
| Marketable Securities | 165,336 | 41,404 | 40,865 | 38,531 | N/A |
| Receivables | 116 | 217 | 142 | 999 | 1,165 |
| Other current assets | 0 | 0 | 0 | 5,266 | 5,301 |
| TOTAL | $231,160 | $270,172 | $294,237 | $188,200 | $16,837 |
| Non-Current Assets | |||||
| PPE Net | 57,321 | 43,792 | 14,747 | 14,302 | 5,576 |
| Intangibles | 50,000 | 74,062 | 74,062 | 74,062 | 74,062 |
| Other Non-Current Assets | 2,620 | 3,127 | 2,873 | 1,722 | 1,416 |
| TOTAL | $109,941 | $120,981 | $91,682 | $90,086 | $81,054 |
| Total Assets | $341,101 | $391,153 | $385,919 | $278,286 | $97,891 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,343 | 21,813 | 6,127 | 6,027 | 6,909 |
| Accrued Expenses | 5,478 | 3,976 | 2,309 | 1,828 | 3,588 |
| Other current liabilities | N/A | N/A | N/A | 5,070 | 5,072 |
| TOTAL | $18,230 | $28,143 | $10,610 | $14,503 | $15,664 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,625 | 1,638 | 1,651 | 1,663 | 1,676 |
| Deferred Revenues | 1,400 | 1,400 | 1,400 | 1,400 | N/A |
| Other Non-Current Liabilities | 1,483 | 1,709 | 1,469 | 1,037 | 780 |
| TOTAL | $32,203 | $34,539 | $34,312 | $33,892 | $7,048 |
| Total Liabilities | $50,433 | $62,682 | $44,922 | $48,395 | $22,712 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 74,052 | 67,588 | 67,428 | 62,263 | 58,692 |
| Common Shares | 70 | 67 | 67 | 587 | 28 |
| Retained earnings | -231,719 | -191,550 | -176,428 | -164,724 | -152,440 |
| Other shareholders' equity | -51 | 0 | 0 | 0 | 0 |
| TOTAL | $290,668 | $328,471 | $340,997 | $229,891 | $75,179 |
| Total Liabilities And Equity | $341,101 | $391,153 | $385,919 | $278,286 | $97,891 |